CS logo
small CS logo
Department of SICU, Research Institute of General Surgery Jinling Hospital, Nanjing, Jiangsu, China

Nanjing, Jiangsu, China

About Department of SICU, Research Institute of General Surgery Jinling Hospital, Nanjing, Jiangsu, China


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Department of SICU, Research Institute of General Surgery Jinling Hospital, Nanjing, Jiangsu, China


During the past decade, Department of SICU, Research Institute of General Surgery Jinling Hospital, Nanjing, Jiangsu, China conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Department of SICU, Research Institute of General Surgery Jinling Hospital, Nanjing, Jiangsu, China" #1 collaborator was "Clinical Medical College of Yangzhou University" with 1 trials as a collaborator, "Jiangsu Province Hospital of Traditional Chinese Medicine" with 1 trials as a collaborator, "Luoyang Central Hospital" with 1 trials as a collaborator, "Qilu Hospital of Shandong University" with 1 trials as a collaborator and "Second Affiliated Hospital of Nantong University" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

Clinical Trials Conditions at Department of SICU, Research Institute of General Surgery Jinling Hospital, Nanjing, Jiangsu, China


According to Clinical.Site data, the most researched conditions in "Department of SICU, Research Institute of General Surgery Jinling Hospital, Nanjing, Jiangsu, China" are "Pancreatitis, Acute Necrotizing" (2 trials) and "Acute Pancreatitis" (1 trials). Many other conditions were trialed in "Department of SICU, Research Institute of General Surgery Jinling Hospital, Nanjing, Jiangsu, China" in a lesser frequency.

Clinical Trials Intervention Types at Department of SICU, Research Institute of General Surgery Jinling Hospital, Nanjing, Jiangsu, China


Most popular intervention types in "Department of SICU, Research Institute of General Surgery Jinling Hospital, Nanjing, Jiangsu, China" are "Drug" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Continuous regional arterial infusion of low molecular weight heparin in celiac trunk" (1 trials), "General treatment" (1 trials), "Infusion" (1 trials), "Thymosin Alpha 1" (1 trials) and "normal saline" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Department of SICU, Research Institute of General Surgery Jinling Hospital, Nanjing, Jiangsu, China


The vast majority of trials in "Department of SICU, Research Institute of General Surgery Jinling Hospital, Nanjing, Jiangsu, China" are 3 trials for "All" genders.

Clinical Trials Status at Department of SICU, Research Institute of General Surgery Jinling Hospital, Nanjing, Jiangsu, China


Currently, there are NaN active trials in "Department of SICU, Research Institute of General Surgery Jinling Hospital, Nanjing, Jiangsu, China". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Department of SICU, Research Institute of General Surgery Jinling Hospital, Nanjing, Jiangsu, China, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Department of SICU, Research Institute of General Surgery Jinling Hospital, Nanjing, Jiangsu, China, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".